Synlogic, Inc. (LON:0A8U)
1.505
-0.097 (-6.04%)
At close: Jul 31, 2025
Elevation Oncology Revenue
In the year 2024, Synlogic had annual revenue of $8.00K USD, down -99.76%.
Revenue
$8.00K
Revenue Growth
-99.76%
P/S Ratio
n/a
Revenue / Employee
$8.00K
Employees
1
Market Cap
13.07M
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 8.00K | -3.36M | -99.76% |
Dec 31, 2023 | 3.37M | 2.19M | 185.68% |
Dec 31, 2022 | 1.18M | -574.00K | -32.73% |
Dec 31, 2021 | 1.75M | 1.21M | 221.83% |
Dec 31, 2020 | 545.00K | -1.68M | -75.49% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
HSBC Holdings | 41.03B |
Shell | 217.54B |
Unilever | 50.25B |
British American Tobacco p.l.c. | 25.87B |
Rolls-Royce Holdings | 18.91B |
Rio Tinto Group | 39.22B |
RELX PLC | 9.53B |
Synlogic News
- 9 months ago - Synlogic Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 1 year ago - Synlogic Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 1 year ago - Synlogic Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 1 year ago - Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 1 year ago - Synlogic Adopts Limited Duration Stockholders Rights Plan - GlobeNewsWire
- 1 year ago - Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update - GlobeNewsWire
- 1 year ago - Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria - GlobeNewsWire
- 1 year ago - Synlogic Provides Corporate Update and Outlook for 2024 - GlobeNewsWire